PLX   $1.69  1.81% Market Closed After Close 1.6924 0.14%

Protalix Biotherapeutics Inc
Total Cash 45.03M
totalCashPerShare 0.612
EBITDA -13.53M
Total Debt 26.15M
quickRatio 0.951
currentRatio 1.335
Total Revenue 38.05M
debtToEquity 91.501
Revenue/Share 0.522
ROA -0.1027
ROE -0.43485
grossProfits
freeCashflow 1.32M
operatingCashflow -2.71M
earningsGrowth
revenueGrowth -0.616
grossMargins 0.32181
ebitdaMargins -0.35544997
operatingMargins -0.18011999
profitMargins -0.38615
enterpriseValue 76.73M
forwardPE 2.096774
floatShares 54.65M
sharesOutstanding 73.54M
sharesShort 3.10M
sharesShortPriorMonth 3.27M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.15%
heldPercentInstitutions 0.08%
Short Ratio help_outline 24.16%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 0.39
Price To Book help_outline 3.33
earningsQuarterlyGrowth
netIncomeToCommon -14.69M
trailingEps -0.23%
forwardEps 0.62%
enterpriseToEbitda -5.67
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.04 3Q 2024
institutionsCount 77
lastUpdated Nov. 6, 2024, 4:29 p.m.